查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018831

內視鏡設備市場：2026-2032年全球市場預測（以內視鏡類型、應用、用途、最終用戶和通路分類）

Endoscopy Devices Market by Endoscope Type, Application, Usage Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡設備市場價值將達到 506.1 億美元，到 2026 年將成長至 543.3 億美元，到 2032 年將達到 834.9 億美元，複合年成長率為 7.41%。

主要市場統計數據
基準年 2025 506.1億美元
預計年份：2026年 543.3億美元
預測年份 2032 834.9億美元
複合年成長率 (%) 7.41%

權威概述了臨床需求、技術進步和採購重點如何改變現代內視鏡設備的市場結構。

內視鏡設備領域處於臨床需求、技術創新和複雜供應鏈動態的交會點。近年來，臨床醫生對高解析度成像、微創診斷和治療方法以及能夠降低感染風險並簡化工作流程的一次性耗材提出了更高的要求。同時，光學、感測器小型化、機器人技術和軟體主導的可視化技術的進步拓展了臨床應用範圍，並重新定義了操​​作標準。這些變化使得內視鏡的功能從最初的診斷擴展到多學科的治療和混合應用。

技術進步、對感染預防的日益重視以及供應鏈的重組，都在促使整個內視鏡市場發生深刻的結構性變化。

內視鏡產業正經歷一場變革性的轉型，技術、臨床和市場因素的整合正在重塑手術流程和供應模式。首先，影像技術的穩定成熟以及人工智慧（AI）在診斷影像中的應用，使得早期診斷更加精準，同時也促進了微創治療性介入。這些進步提升了膠囊內視鏡、軟式影像內視鏡和硬式內視鏡在更廣泛適應症的臨床效用。其次，對感染預防的持續關注加速了一次性內視鏡的普及，同時也推動了可重複使用內視鏡系統的高級消毒和再處理流程的改進，從而形成了既競爭又共存的平行產品管道。

評估 2025 年美國對內視鏡產業徵收關稅對採購、籌資策略和供應鏈韌性的多面向影響。

2025年新關稅措施的實施進一步加劇了內視鏡設備製造商、契約製造製造商和設備零件供應商的全球籌資策略的複雜性。關稅政策可能會影響成像感測器、光學組件、光源和電子控制模組的總成本，而這些組件通常透過國際供應鏈網路採購。在貿易壁壘日益加深的背景下，採購團隊正在加強對近岸外包、雙重採購和策略性庫存管理策略的評估，以降低關稅和運輸成本波動帶來的風險。同時，供應商和原始設備製造商（OEM）也正在重新評估合約條款，以確定是將額外成本轉嫁給客戶還是自行承擔課稅，從而保持競爭優勢。

透過對設備類型、臨床應用、使用模式、最終用戶和分銷管道進行詳細的細分分析，可以揭示可操作的策略見解。

一套精細的市場細分框架揭示了每種產品類別、臨床應用、使用模式、最終用戶和分銷管道的不同市場進入曲線和投資重點。基於內視鏡類型，市場細分為膠囊內視鏡、軟式內視鏡和硬式內視鏡，每種內視鏡在可視化、操作和治療整合方面各有優勢，並需要不同的維護和消毒流程。基於應用，市場細分為關節鏡、胃腸內視鏡檢查、腹腔鏡檢查和泌尿系統內視鏡檢查。關節鏡類別進一步細分為髖關節內視鏡檢查、膝關節內關節鏡和肩關節關節鏡，反映了對專用器材和診斷影像的需求。在胃腸內視鏡檢查領域，分析涵蓋大腸鏡檢查、內視鏡超音波、ERCP 和胃鏡檢查，揭示了不同診斷和治療功能在裝置需求和配套系統方面的差異。腹腔鏡領域進一步細分，並按普通腹腔鏡、婦科腹腔鏡和兒童腹腔鏡進行詳細研究，重點關注其在尺寸、人體工學和照明方面的差異。在泌尿系統內視鏡領域，膀胱結石碎石術、膀胱鏡檢查和輸尿管鏡檢查也進行了更深入的研究，這些檢查在入路、能量供應和灌注管理方面存在差異。

了解區域臨床重點、報銷結構和製造地如何影響全球內視鏡市場採用模式的差異。

區域趨勢對全球內視鏡市場的採用模式、監管考量和競爭策略有顯著影響。在美洲，大規模醫院網路、成熟的門診手術體係以及支付方對手術能力和感染控制的重視，正深刻地影響市場需求。這些因素推動了對高性能軟式內視鏡、特定環境下的一次性內視鏡以及整合式成像平台的強勁需求。在歐洲和中東及非洲，不同的管理體制和採購結構導致了不同的採用模式。一些市場優先考慮集中採購和基於價值的契約，而另一些市場則專注於私人門診機構的發展，這為模組化和可配置解決方案創造了區域差異化的機會。在亞太地區，醫療基礎設施的快速擴張、手術量的增加以及對微創技術的日益關注，推動了對經濟高效、可重複使用系統和創新型一次性內視鏡設計的需求，同時也提升了本地製造地和區域供應商的戰略重要性。

在內視鏡領域，成熟企業、創新者和服務夥伴如何透過平台策略、臨床證據產生和夥伴關係進行協作，從而有效地展開競爭？

內視鏡領域的競爭動態取決於規模經濟、平台創新和服務卓越三者之間的平衡。擁有成熟手術和大型設備產品組合的醫療設備製造商憑藉其廣泛的臨床關係、完善的服務網路和豐富的監管經驗，在軟式和硬式內視鏡等關鍵領域保持領先地位。同時，專業公司和Start-Ups透過在膠囊內視鏡技術、一次性內視鏡、先進成像感測器和人工智慧視覺化工具等領域推出針對性創新，挑戰著傳統的價值提案。這些新參與企業通常採用基於最小資產的商業化模式，並與契約製造和當地分銷商合作，以加速市場進入。

為市場領導提供切實可行的策略性舉措，以增強供應韌性，加速在臨床環境中的應用，並透過服務和證據實現差異化。

產業領導者可以透過採取切實可行的多面向策略，將市場複雜性轉化為機遇，這些策略旨在滿足臨床需求、確保供應連續性並實現商業性差異化。首先，優先考慮模組化產品架構和供應商多元化，以降低單一供應商帶來的風險，並在貿易政策或物流中斷時實現快速零件更換。其次，加速臨床證據項目，量化效率提升、感染控制效益和治療效果，從而縮短採購評估週期，並加強基於價值的採購對話。第三，透過針對門診手術中心、醫院和專科診所調整特定產品配置，建立清晰的市場細分，以反映處理能力、預算週期和臨床工作流程的差異。

為了支持策略建議，我們採用了嚴謹的混合研究途徑，結合了臨床醫生的第一手資料、第二手檢驗和三角測量分析。

本研究採用混合方法，整合了與一手專家的對話、結構化的二手資料分析以及多方面的檢驗，以確保獲得可靠且可操作的見解。一手資訊透過與臨床醫生、醫院系統和門診手術中心的採購經理、監管專家以及行業高管的深入訪談收集，以了解實際限制、未滿足的臨床需求以及推廣應用的障礙。二手資料分析利用同行評審的臨床文獻、監管文件、專利趨勢以及公開的企業資訊披露，檢驗技術進步和競爭地位。資料三角驗證透過交叉引用供應商訪談、最終用戶回饋和監管文件，整合了不同的觀點。

全面概述如何協調創新、臨床檢驗和供應鏈韌性，以在不斷變化的內視鏡醫學領域中獲得策略優勢。

總之，內視鏡設備生態系統正處於一個轉折點，技術進步和不斷演進的醫療服務模式與供應鏈和政策的阻力交織在一起。儘管不斷擴展的成像能力、人工智慧成像技術以及日益增多的微創治療方案正在改變臨床實踐，但感染控制、成本控制和受關稅驅動的採購決策等壓力也在影響著商業策略。這些因素既帶來了挑戰，也帶來了機會。能夠快速整合產品設計、臨床證據產生和靈活生產能力的製造商將超越那些依賴傳統模式的競爭對手。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡設備市場：以內視鏡類型分類

  • 膠囊內視鏡
  • 軟式內視鏡
  • 硬式內視鏡

第9章 內視鏡設備市場：依應用領域分類

  • 關節鏡
    • 髖關節鏡檢查
    • 膝關節關節鏡
    • 肩關節關節鏡
  • 胃腸內視鏡檢查
    • 大腸鏡檢查
    • 內視鏡超音波
    • ERCP
    • 胃鏡檢查
  • 腹腔鏡
    • 普通腹腔鏡
    • 婦科腹腔鏡
    • 兒童腹腔鏡手術
  • 泌尿系統視鏡檢查
    • 膀胱結石體外震波碎石術
    • 膀胱鏡檢查
    • 輸尿管鏡檢查

第10章 內視鏡設備市場依應用領域分類

  • 可重複使用的內視鏡
  • 免洗內視鏡

第11章 內視鏡設備市場：依最終用戶分類

  • 日間手術中心
  • 醫院
  • 專科診所

第12章 內視鏡設備市場：依通路分類

  • 直銷
  • 透過分銷商銷售

第13章 內視鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 內視鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國內視鏡設備市場

第17章：中國內視鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Asensus Surgical, Inc.
  • Auris Health, Inc.
  • avateramedical GmbH
  • Boston Scientific Corporation
  • Brainlab AG
  • CMR Surgical Ltd.
  • Conmed Corporation
  • Cook Group Incorporated
  • Endocontrol SA by Canady Life Sciences, Inc.
  • EndoMaster Pte Ltd
  • Endotics
  • FUJIFILM Holdings Corporation
  • Globus Medical, Inc.
  • HOYA Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Renishaw PLC
  • Smith & Nephew plc
  • Stryker Corporation
  • Virtuoso Surgical, Inc.
Product Code: MRR-ED54C46E8C23

The Endoscopy Devices Market was valued at USD 50.61 billion in 2025 and is projected to grow to USD 54.33 billion in 2026, with a CAGR of 7.41%, reaching USD 83.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 50.61 billion
Estimated Year [2026] USD 54.33 billion
Forecast Year [2032] USD 83.49 billion
CAGR (%) 7.41%

An authoritative overview of how clinical demand, technological advances, and procurement priorities are reshaping the modern endoscopy devices landscape

The field of endoscopy devices sits at the intersection of clinical necessity, technological innovation, and complex supply chain dynamics. In recent years clinicians have demanded higher-resolution imaging, less invasive diagnostic and therapeutic approaches, and disposable options that reduce infection risk and streamline workflow. Simultaneously, technological progress in optics, sensor miniaturization, robotics, and software-driven visualization has expanded clinical capabilities and reshaped procedural standards. These shifts have elevated endoscopy from primarily diagnostic roles into therapeutic and hybrid applications across multiple specialties.

Meanwhile, health systems and outpatient providers emphasize efficiency, throughput, and total cost of care, prompting procurement teams to weigh lifecycle maintenance against single-use convenience. New regulatory scrutiny and growing emphasis on post-market surveillance have further influenced product design and commercialization strategies. As a result, manufacturers, hospital systems, and policy-makers navigate a rapidly evolving ecosystem where clinical outcomes, economic constraints, and innovation cycles converge. This introduction frames the broader landscape and sets expectations for subsequent sections that analyze transformative shifts, tariff impacts, segmentation nuances, regional dynamics, competitor behavior, recommended actions, methodological rigor, and concluding perspectives.

How converging technological advances, infection prevention priorities, and supply chain realignments are driving deep structural change across endoscopy markets

The endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and market forces that are redefining procedure paradigms and supply models. First, the steady maturation of imaging technologies and integration of artificial intelligence into image interpretation are enabling earlier and more accurate diagnoses while facilitating minimally invasive therapeutic interventions. These advances increase the clinical utility of capsule systems, flexible video endoscopes, and rigid scopes across a wider set of indications. Second, the persistent focus on infection prevention has accelerated uptake of single use endoscopes alongside improvements in high-level disinfection and reprocessing protocols for reusable systems, thereby creating parallel product pathways that compete and coexist.

Third, procedural migration from inpatient operating rooms to ambulatory surgery centers and specialty clinics is reshaping workflow expectations and device form factors, prompting manufacturers to optimize for portability, sterilization ease, and rapid turnover. Fourth, supply chain localization, strategic component sourcing, and heightened regulatory scrutiny are forcing organizations to re-evaluate supplier relationships and manufacturing footprints. Lastly, new entrants and cross-sector collaborations are introducing modular platforms, software-as-a-service offerings, and integrated procedural suites that compel incumbents to move faster on partnerships and platform strategies. Together, these shifts are not incremental; they form a composite of disruptive trends that will influence product roadmaps, go-to-market models, and clinical adoption curves over the coming years.

Assessing the multifaceted consequences of 2025 United States tariff actions on procurement, sourcing strategies, and supply chain resilience in endoscopy

The introduction of new tariff measures in 2025 has introduced additional complexity into global sourcing strategies for endoscopy device manufacturers, contract manufacturers, and device component suppliers. Tariff policy can influence the landed cost of imaging sensors, optics assemblies, light sources, and electronic control modules that are frequently sourced across international supply networks. As trade barriers rise, procurement teams increasingly evaluate nearshoring, dual-sourcing, and strategic inventory policies to mitigate exposure to customs duties and transportation volatility. In parallel, suppliers and OEMs reassess contractual terms to pass through incremental cost or to absorb levies as part of competitive positioning.

Beyond direct cost implications, tariffs alter supplier bargaining power and can lengthen qualification timelines for alternate vendors. This dynamic affects product launch schedules and can delay clinical rollouts when critical components are tied to specific suppliers. Moreover, tariff-driven shifts interact with regulatory and reimbursement environments, creating cascading effects on pricing strategies, contract negotiations with health systems, and decisions about product modularity to allow for variant sourcing. To manage these cumulative impacts, industry players are prioritizing scenario planning, enhancing visibility into multi-tier supply chains, and accelerating investments in localized manufacturing capacity where feasible. These responses aim to preserve clinical availability, control total landed cost, and maintain competitive differentiation despite a more fragmented global trade environment.

Detailed segmentation analysis linking device typologies, clinical applications, usage models, end users, and distribution channels to reveal practical strategic insights

A nuanced segmentation framework reveals distinct adoption curves and investment priorities across product classes, clinical applications, usage models, end users, and distribution channels. Based on Endoscope Type, the market is studied across Capsule Endoscopes, Flexible Endoscopes, and Rigid Endoscopes, each offering differing capabilities for visualization, access, and therapeutic integration and requiring tailored service and sterilization protocols. Based on Application, the market is studied across Arthroscopy, Gastrointestinal Endoscopy, Laparoscopy, and Urological Endoscopy; the Arthroscopy category is further studied across Hip Arthroscopy, Knee Arthroscopy, and Shoulder Arthroscopy, reflecting specialized instrumentation and imaging needs. Within Gastrointestinal Endoscopy, the analysis covers Colonoscopy, Endoscopic Ultrasound, ERCP, and Gastroscopy, highlighting how diagnostic and interventional functions diverge in device requirements and accessory ecosystems. The Laparoscopy segment is further studied across General Laparoscopy, Gynecological Laparoscopy, and Pediatric Laparoscopy, emphasizing size, ergonomics, and illumination differences. The Urological Endoscopy segment is further studied across Cystolithotripsy, Cystoscopy, and Ureteroscopy, which vary by channel access, energy delivery, and irrigation management.

Based on Usage Type, the market is studied across Reusable Endoscopes and Single Use Endoscopes, an axis that captures the trade-offs between capital investment, reprocessing infrastructure, cross-infection risk, and per-procedure economics. Based on End User, the market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, each exhibiting different purchasing cycles, procedural volumes, and staffing models that influence device selection. Based on Distribution Channel, the market is studied across Direct Sales and Distributor Sales, which correspond to manufacturer control over pricing, service relationships, and market reach. Together, these segmentation lenses provide a comprehensive map for understanding where clinical need, economic drivers, and commercial execution intersect to create differentiated opportunities and risks.

Understanding how regional clinical priorities, reimbursement structures, and manufacturing footprints drive divergent adoption patterns across global endoscopy markets

Regional dynamics materially influence adoption patterns, regulatory considerations, and competitive strategies across the global endoscopy landscape. In the Americas, demand is strongly shaped by large hospital networks, a mature outpatient surgical ecosystem, and payer dynamics that prioritize procedural throughput and infection control; these drivers translate into robust demand for high-performance flexible endoscopes, disposable options in select settings, and integrated imaging platforms. In Europe, Middle East & Africa, diverse regulatory regimes and purchasing structures lead to heterogeneous adoption; some markets favor centralized procurement and value-based contracting while others emphasize private ambulatory growth, creating a patchwork of opportunities for modular and configurable solutions. In the Asia-Pacific region, rapid expansion of healthcare infrastructure, growing procedural volumes, and a rising emphasis on minimally invasive techniques are fueling interest in both cost-efficient reusable systems and innovative single use designs, while local manufacturing footprints and regional suppliers are gaining strategic importance.

Across regions, the pace of technology adoption correlates with clinical training availability, reimbursement incentives, and supply chain maturity. Consequently, manufacturers must tailor regulatory strategies, service models, and pricing approaches to address regional variations in hospital procurement, ambulatory center proliferation, and specialty clinic expansion. In addition, cross-border trade policies and regional manufacturing investments will continue to shape where companies locate assembly, final testing, and after-sales support to optimize responsiveness to clinicians and healthcare purchasers.

How incumbents, innovators, and service partners are converging on platform strategies, clinical evidence generation, and partnerships to compete effectively in endoscopy

Competitive dynamics in endoscopy hinge on a balance between scale-based advantages, platform innovation, and service excellence. Incumbent medical device manufacturers with established surgical and capital equipment portfolios often leverage broad clinical relationships, integrated service networks, and regulatory experience to maintain leadership in core segments such as flexible and rigid endoscopes. At the same time, specialist firms and startups are introducing targeted innovations in capsule technology, single use scopes, advanced imaging sensors, and AI-enabled visualization tools that challenge traditional value propositions. These entrants frequently adopt asset-light commercialization models and partner with contract manufacturers or local distributors to accelerate market entry.

Strategic partnerships and M&A continue to be important mechanisms for incumbents to fill technological gaps, acquire niche capabilities, or expand into adjacent therapeutic areas. In parallel, supply chain partners and third-party reprocessors are reshaping total cost of ownership debates by offering alternative servicing models and warranty structures. To sustain competitive advantage, companies are prioritizing investments in digital ecosystems, clinical evidence generation, and training programs that reduce adoption friction. Equally important is the ability to demonstrate outcomes, safety, and efficiency improvements in real-world settings, as purchasing committees increasingly demand data-driven justification for capital and consumable selection. Overall, the market rewards firms that can align technological differentiation with scalable commercial execution and strong clinical validation.

Actionable strategic initiatives for market leaders to fortify supply resilience, accelerate clinical adoption, and differentiate through service and evidence

Industry leaders can translate market complexity into opportunity by adopting a pragmatic, multidimensional strategy that addresses clinical needs, supply continuity, and commercial differentiation. First, prioritize modular product architectures and supplier diversification to reduce single-source risk and enable rapid component substitution when trade policy or logistics disruptions occur. Second, accelerate clinical evidence programs that quantify efficiency gains, infection control benefits, and procedural outcomes, thereby shortening procurement evaluation cycles and reinforcing value-based purchasing conversations. Third, develop clear go-to-market segmentation by aligning specific product configurations with Ambulatory Surgery Centers, Hospitals, and Specialty Clinics to reflect differences in throughput, budget cycles, and clinical workflows.

Fourth, invest in flexible service models that combine remote diagnostics, predictive maintenance, and outcome-linked support to improve device uptime and reduce total cost of care for end users. Fifth, evaluate selective localization or nearshoring for critical subassemblies to mitigate tariff exposure while preserving cost competitiveness. Sixth, pursue partnerships and co-development agreements to accelerate access to AI, robotic, and sensor innovations without incurring full internal development overhead. Finally, embed a regulatory and reimbursement intelligence function within strategic planning to anticipate policy shifts and to adapt product labeling, clinical trial design, and market access tactics proactively. Implementing these recommendations can help leaders convert disruption into differentiation and build resilient growth pathways.

A rigorous hybrid research approach combining primary clinician insights, secondary validation, and triangulated analysis to underpin strategic recommendations

This research employs a hybrid methodology that integrates primary expert engagement, structured secondary analysis, and multi-source triangulation to ensure robust, actionable findings. Primary inputs include in-depth discussions with practicing clinicians, procurement leaders across hospital systems and ambulatory centers, regulatory specialists, and industry executives to capture real-world operational constraints, unmet clinical needs, and adoption barriers. Secondary analysis draws on peer-reviewed clinical literature, regulatory filings, patent landscapes, and publicly reported corporate disclosures to validate technology trajectories and competitive positioning. Data triangulation reconciles divergent perspectives by cross-referencing supplier interviews with end-user feedback and regulatory documentation.

Analytical processes include segmentation mapping across product type, application, usage model, end user, and distribution channel, along with scenario analysis that examines supply chain, policy, and technology perturbations. Quality assurance procedures encompass source verification, expert panel review, and consistency checks across chapters to maintain interpretive integrity. Where relevant, methodological notes outline limitations, such as the evolving nature of tariff policy and the pace of clinical adoption, and indicate areas where ongoing monitoring will be beneficial. The result is a structured body of evidence designed to support strategic planning, procurement decision-making, and R&D prioritization while acknowledging inherent uncertainties in a dynamic market.

Closing perspectives on aligning innovation, clinical validation, and supply resilience to capture strategic advantage in an evolving endoscopy landscape

In conclusion, the endoscopy devices ecosystem is at an inflection point where technological progress and changing care delivery models are intersecting with supply chain and policy headwinds. The expansion of imaging capabilities, AI-assisted interpretation, and minimally invasive therapeutic options is transforming clinical practice, while parallel pressures around infection control, cost containment, and tariff-driven sourcing decisions shape commercial strategy. These forces create both tension and opportunity: manufacturers that can rapidly align product design, clinical evidence generation, and flexible manufacturing will outpace competitors that rely on legacy models.

Looking ahead, successful stakeholders will be those who integrate rigorous scenario planning into procurement and product roadmaps, partner strategically to complement internal capabilities, and maintain a disciplined focus on outcomes that matter to clinicians and payers. By synthesizing segmentation-specific insights with regional realities and supply chain considerations, decision-makers can identify targeted investments that enhance resilience, accelerate adoption, and preserve margins. The conclusion underscores a pragmatic imperative: anticipate change proactively, validate innovations in real-world settings, and structure commercial models to capture value across an increasingly complex and opportunity-rich endoscopy landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Devices Market, by Endoscope Type

  • 8.1. Capsule Endoscopes
  • 8.2. Flexible Endoscopes
  • 8.3. Rigid Endoscopes

9. Endoscopy Devices Market, by Application

  • 9.1. Arthroscopy
    • 9.1.1. Hip Arthroscopy
    • 9.1.2. Knee Arthroscopy
    • 9.1.3. Shoulder Arthroscopy
  • 9.2. Gastrointestinal Endoscopy
    • 9.2.1. Colonoscopy
    • 9.2.2. Endoscopic Ultrasound
    • 9.2.3. ERCP
    • 9.2.4. Gastroscopy
  • 9.3. Laparoscopy
    • 9.3.1. General Laparoscopy
    • 9.3.2. Gynecological Laparoscopy
    • 9.3.3. Pediatric Laparoscopy
  • 9.4. Urological Endoscopy
    • 9.4.1. Cystolithotripsy
    • 9.4.2. Cystoscopy
    • 9.4.3. Ureteroscopy

10. Endoscopy Devices Market, by Usage Type

  • 10.1. Reusable Endoscopes
  • 10.2. Single Use Endoscopes

11. Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endoscopy Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopy Devices Market

17. China Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Asensus Surgical, Inc.
  • 18.7. Auris Health, Inc.
  • 18.8. avateramedical GmbH
  • 18.9. Boston Scientific Corporation
  • 18.10. Brainlab AG
  • 18.11. CMR Surgical Ltd.
  • 18.12. Conmed Corporation
  • 18.13. Cook Group Incorporated
  • 18.14. Endocontrol SA by Canady Life Sciences, Inc.
  • 18.15. EndoMaster Pte Ltd
  • 18.16. Endotics
  • 18.17. FUJIFILM Holdings Corporation
  • 18.18. Globus Medical, Inc.
  • 18.19. HOYA Corporation
  • 18.20. Intuitive Surgical, Inc.
  • 18.21. Johnson & Johnson
  • 18.22. Karl Storz SE & Co. KG
  • 18.23. Medtronic plc
  • 18.24. MicroPort Scientific Corporation
  • 18.25. Olympus Corporation
  • 18.26. Otsuka Holdings Co., Ltd.
  • 18.27. Renishaw PLC
  • 18.28. Smith & Nephew plc
  • 18.29. Stryker Corporation
  • 18.30. Virtuoso Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)